RT Journal Article
SR Electronic
T1 Two new treatment options for infections due to drug-resistant gram-positive cocci
JF Cleveland Clinic Journal of Medicine
JO Cleve Clin J Med
FD Cleveland Clinic
SP 397
OP 413
VO 69
IS 5
A1 Susan J. Rehm
YR 2002
UL http://www.ccjm.org/content/69/5/397.abstract
AB Gram-positive cocci, including enterococci and Staphylococcus aureus, have become the leading cause of hospital-acquired infections, and their resistance to antibiotics is increasing.Two important new drugs—quinupristin/dalfopristin (Synercid) and linezolid (Zyvox)—were designed specifically to treat infections due to drug-resistant gram-positive cocci. But their use must be tempered by their cost, toxicity, and concerns about further development of resistant strains.